{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:31:29Z","timestamp":1793050289260,"version":"4.5.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s13760-022-01920-5","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T04:40:28Z","timestamp":1648183228000},"page":"871-880","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The ABCB1, ABCC2 and RALBP1 polymorphisms are associated with carbamazepine response in epileptic patient: a systematic review"],"prefix":"10.1007","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7984-3796","authenticated-orcid":false,"given":"Wefa","family":"Boughrara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6004-019X","authenticated-orcid":false,"given":"Amina","family":"Chentouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"issue":"4","key":"1920_CR1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/epi.12550","volume":"55","author":"RS Fisher","year":"2014","unstructured":"Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE et al (2014) ILAE official report: a practical clinical definition of epilepsy. Epilepsia 55(4):475\u2013482","journal-title":"Epilepsia"},{"key":"1920_CR2","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.ncl.2016.06.015","volume":"34","author":"A Singh","year":"2016","unstructured":"Singh A, Trevick S (2016) The epidemiology of global epilepsy. Neurol Clin 34:837\u2013847. https:\/\/doi.org\/10.1016\/j.ncl.2016.06.015","journal-title":"Neurol Clin"},{"issue":"3","key":"1920_CR3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1212\/WNL.0000000000003509","volume":"88","author":"KM Fiest","year":"2017","unstructured":"Fiest KM, Sauro KM, Wiebe S, Patten SB, Kwon C-S, Dykeman J, Pringsheim T, Lorenzetti DL, Jett\u00e9 N (2017) Prevalence and incidence of epilepsy A systematic review and meta-analysis of international studies. Neurology 88(3):296\u2013303","journal-title":"Neurology"},{"key":"1920_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000503831","volume":"54","author":"E Beghi","year":"2020","unstructured":"Beghi E (2020) The epidemiology of epilepsy. Neuroepidemiology 54:185\u2013191","journal-title":"Neuroepidemiology"},{"key":"1920_CR5","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nrd4126","volume":"12","author":"W Loscher","year":"2013","unstructured":"Loscher W, Klitgaard H, Twyman RE, Schmidt D (2013) New avenues for anti-epileptic drug discovery and development. Nat Rev Drug Discov 12:757\u2013776. https:\/\/doi.org\/10.1038\/nrd4126","journal-title":"Nat Rev Drug Discov"},{"key":"1920_CR6","first-page":"990","volume-title":"Merritt\u2019s neurology","author":"CW Bazil","year":"2005","unstructured":"Bazil CW, Morrell MJ, Pedley TA (2005) Epilepsy. In: Rowland LP (ed) Merritt\u2019s neurology, 11th edn. Lippincott Williams & Wilkins, Philadelphia, pp 990\u20131008","edition":"11"},{"key":"1920_CR7","first-page":"461","volume-title":"Goodman & Gilman\u2019s. The pharmacological basis of therapeutics","author":"JO McNamara","year":"2019","unstructured":"McNamara JO (2019) Drugs effective in the therapy of the epilepsies. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW (eds) Goodman & Gilman\u2019s. The pharmacological basis of therapeutics, 9th edn. McGraw-Hill, New York, pp 461\u2013486","edition":"9"},{"issue":"12","key":"1920_CR8","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/phar.1855","volume":"36","author":"MSA Campos","year":"2016","unstructured":"Campos MSA, Ayres LR, Morelo MRS, Marques FA, Pereira LRL (2016) Efficacy and tolerability of antiepileptic drugs in patients with focal epilepsy: systematic review and network meta-analyses. Pharmacotherapy 36(12):1255\u20131271","journal-title":"Pharmacotherapy"},{"issue":"7","key":"1920_CR9","first-page":"392","volume":"35","author":"MM Goldenberg","year":"2010","unstructured":"Goldenberg MM (2010) Overview of drugs used for epilepsy and seizures etiology, diagnosis, and treatment. P&T 35(7):392\u2013415","journal-title":"P&T"},{"key":"1920_CR10","first-page":"829","volume":"266","author":"DG Lang","year":"1993","unstructured":"Lang DG, Wang CM, Cooper BR (1993) Lamotrigine, phenytoin, and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells. J Pharmacol ExpTher 266:829\u2013835","journal-title":"J Pharmacol ExpTher"},{"issue":"Suppl","key":"1920_CR11","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1111\/j.1528-1157.1995.tb05996.x","volume":"36","author":"RL Macdonald","year":"1995","unstructured":"Macdonald RL, Kelly KM (1995) Antiepileptic drug mechanisms of action. Epilepsia 36(Suppl):S2-12","journal-title":"Epilepsia"},{"key":"1920_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.103","author":"SG Leckband","year":"2013","unstructured":"Leckband SG, Kelsoe JR, Dunnenberger HM, George AL, Tran E, Berger R et al (2013) Clinical pharmacogenetics implementation consortium guidelines for HLA-B genotype and carbamazepine dosing. Clin Pharmacol Ther. https:\/\/doi.org\/10.1038\/clpt.2013.103","journal-title":"Clin Pharmacol Ther"},{"key":"1920_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/0253-7613.108280","volume":"45","author":"CS Shastry","year":"2013","unstructured":"Shastry CS, Shafeeque AA, Ashwathnarayana BJ (2013) Effect of combination of aripiprazole with carbamazepine and fluvoxamine on liver functions in experimental animals. Indian J Pharmacol 45:121\u2013125","journal-title":"Indian J Pharmacol"},{"issue":"86\u201398","key":"1920_CR14","first-page":"4","volume":"16","author":"E Yukawa","year":"2000","unstructured":"Yukawa E (2000) Investigation of phenobarbital-carbamazepinevalproic acid interactions using population pharmacokinetic analysis for optimisation of antiepileptic drug therapy: an overview. Drug Metabol Drug Interact 16(86\u201398):4","journal-title":"Drug Metabol Drug Interact"},{"key":"1920_CR15","doi-asserted-by":"publisher","DOI":"10.1515\/dmdi-2013-0046","author":"NM Jaramillo","year":"2014","unstructured":"Jaramillo NM, Galindo IF, V a zquez AO, Cook HJ, Lerena AL, Lopez ML (2014) Pharmacogenetic potential biomarkers for carbamazepine adverse drug reactions and clinical response. Drug Metab Drug Interact. https:\/\/doi.org\/10.1515\/dmdi-2013-0046","journal-title":"Drug Metab Drug Interact"},{"key":"1920_CR16","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/0006-2952(93)90279-6","volume":"45","author":"S Furst","year":"1993","unstructured":"Furst S, Uetrecht J (1993) Carbamazepine metabolism to a reactive intermediate by the myeloperoxidase system of activated neutrophils. Biochem Pharmacol 45:1267\u20131275","journal-title":"Biochem Pharmacol"},{"key":"1920_CR17","first-page":"51","volume":"288","author":"C Ju","year":"1999","unstructured":"Ju C, Uetrecht JP (1999) Detection of 2-Hydroxyiminostilbene in the urine of patients taking carbamazepine and its oxidation to a reactive iminoquinone intermediate. J PharmacolExpTher 288:51\u201356","journal-title":"J PharmacolExpTher"},{"key":"1920_CR18","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1124\/jpet.104.073114","volume":"311","author":"AG Staines","year":"2004","unstructured":"Staines AG, Coughtrie MW, Burchell B (2004) N-glucuronidation of carbamazepine in human tissues is mediated by UGT2B7. J Pharmacol Exp Ther 311:1131\u20131137","journal-title":"J Pharmacol Exp Ther"},{"key":"1920_CR19","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.mpmed.2012.05.001","volume":"40","author":"RE Ferner","year":"2012","unstructured":"Ferner RE, Butt TF (2012) Adverse drug reactions. Medicine 40:366\u2013370","journal-title":"Medicine"},{"key":"1920_CR20","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/S0140-6736(07)60460-7","volume":"369","author":"AG Marson","year":"2007","unstructured":"Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW et al (2007) The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblended randomised controlled trial. Lancet 369:1000\u20131015","journal-title":"Lancet"},{"key":"1920_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.seizure.2011.12.013","volume":"21","author":"N Ozaras","year":"2012","unstructured":"Ozaras N, Goksugur N, Eroglu S, Tabak O, Canbakan B, Ozaras R (2012) Carbamazepine-induced hypogammaglobulinemia. Seizure 21:229\u2013231","journal-title":"Seizure"},{"issue":"1","key":"1920_CR22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","volume":"455","author":"RL Juliano","year":"1976","unstructured":"Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455(1):152\u2013162","journal-title":"Biochim Biophys Acta"},{"key":"1920_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev.bi.58.070189.001033","volume":"58","author":"JA Endicott","year":"1989","unstructured":"Endicott JA, Ling V (1989) The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 58:137\u2013171","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"1920_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1096\/fasebj.1.1.2886389","volume":"1","author":"MM Cornwell","year":"1987","unstructured":"Cornwell MM, Tsuruo T, Gottesman MM, Pastan I (1987) ATP-binding properties of P-glycoprotein from multidrug-resistant KB cells. Faseb J 1(1):51\u201354","journal-title":"Faseb J"},{"issue":"1","key":"1920_CR25","first-page":"1","volume":"25","author":"R Johnstone","year":"2000","unstructured":"Johnstone R, Ruefli A, Smyth M (2000) Multiple physiological fonctions for multidrug transporter P-Glycoprotein? Tibs 25(1):1\u20136","journal-title":"Tibs"},{"issue":"21","key":"1920_CR26","doi-asserted-by":"publisher","first-page":"7735","DOI":"10.1073\/pnas.84.21.7735","volume":"84","author":"F Thiebaut","year":"1987","unstructured":"Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC (1987) Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84(21):7735\u20137738","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1920_CR27","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/0092-8674(88)90568-5","volume":"53","author":"KH Hoi","year":"1988","unstructured":"Hoi KH, Chen CJ, Kriegler M, Roninson IB (1988) An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the MDR1 (P-glycoprotein) gene. Cell 53(4):519\u2013529","journal-title":"Cell"},{"issue":"2","key":"1920_CR28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/10430340252769815","volume":"13","author":"C Kimchi-Sarfaty","year":"2002","unstructured":"Kimchi-Sarfaty C, Ben-Nun-Shaul O, Rund D, Oppenheim A, Gottesman MM (2002) In vitropackaged SV40 pseudovirions as highly efficient vectors for gene transfer. Hum Gene Ther 13(2):299\u2013310","journal-title":"Hum Gene Ther"},{"issue":"11","key":"1920_CR29","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0006-2952(03)00178-3","volume":"65","author":"N Morita","year":"2003","unstructured":"Morita N, Yasumori T, Nakayama K (2003) Human MDR1 polymorphism: G2677T\/A and C3435T have no effect on MDR1 transport activities. Biochem Pharmacol 65(11):1843\u20131852","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"1920_CR30","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1073\/pnas.97.7.3473","volume":"97","author":"S Hoffmeyer","year":"2000","unstructured":"Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, Cascorbi I, Gerloff T, Roots I, Eichelbaun M, Brinkmann U (2000) Functional polymorphisms of the human multidrug- resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 97(7):3473\u20133478","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"1920_CR31","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/bioinformatics\/bti136","volume":"21","author":"VA Kochetov","year":"2005","unstructured":"Kochetov VA (2005) AUG codons at the beginning of protein coding sequences are frequent in eukaryotic mRNAs with a suboptimal start codon context. Bioinformatics 21(7):837\u2013840","journal-title":"Bioinformatics"},{"issue":"5811","key":"1920_CR32","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1126\/science.1135308","volume":"315","author":"C Kimchi-Sarfaty","year":"2007","unstructured":"Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV, Gottesman MM (2007) A \u201csilent\u201d polymorphism in the MDR1 gene changes substrate specificity. Science 315(5811):525\u2013528","journal-title":"Science"},{"issue":"6","key":"1920_CR33","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/01.fpc.0000197467.21964.67","volume":"16","author":"G Leschziner","year":"2006","unstructured":"Leschziner G, Zabaneh D, Pirmohamed M, Owen A, Rogers J, Coffey AJ, Balding DJ, Bentley DB, Johnson MR (2006) Exon sequencing and high resolution haplotype analysis of ABC transporter genes implicated in drug resistance. Pharmacogenet Genomics 16(6):439\u2013450","journal-title":"Pharmacogenet Genomics"},{"issue":"2","key":"1920_CR34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2133\/dmpk.23.139","volume":"23","author":"K Sai","year":"2008","unstructured":"Sai K, Saito Y, Itoda M, Fukushima-Uesaka H, Nishimaki-Mogami T, Ozawa S, Maekawa K, Kurose K, Kaniwa N, Kawamoto M, Kamatani N et al (2008) Genetic variations and haplotypes of ABCC2 encoding MRP2 in a Japanese population. Drug Metab Pharmacokinet 23(2):139\u2013147","journal-title":"Drug Metab Pharmacokinet"},{"issue":"6","key":"1920_CR35","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/00008571-200208000-00004","volume":"12","author":"K Tang","year":"2002","unstructured":"Tang K, Ngoi SM, Gwee PC, Chua JM, Lee EJ, Chong SS, Lee CG (2002) Distinct haplotype profiles and strong linkage disequilibrium at the mdr1 multidrug transporter gene locus in three ethnic asian populations. Pharmacogenetics 12(6):437\u2013450","journal-title":"Pharmacogenetics"},{"issue":"4","key":"1920_CR36","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1472-8206.2007.00507.x","volume":"21","author":"E Jeannesson","year":"2007","unstructured":"Jeannesson E, Albertini L, Siest G, Gomes AM, Ribeiro V, Aslanidis C, Schmitz G, Visvikis-Siest S (2007) Determination of ABCB1 polymorphisms and haplotypes frequencies in a French population. Fundam Clin Pharmacol 21(4):411\u2013418","journal-title":"Fundam Clin Pharmacol"},{"issue":"5","key":"1920_CR37","first-page":"860","volume":"1794","author":"KL Fung","year":"2009","unstructured":"Fung KL, Gottesman MM (2009) A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function. BiochimBiophys Acta 1794(5):860\u2013871","journal-title":"BiochimBiophys Acta"},{"issue":"5","key":"1920_CR38","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1528-1167.2005.46304.x","volume":"46","author":"GJ Sills","year":"2005","unstructured":"Sills GJ, Mohanraj R, Butler E, McCrindle S, Collier L, Wilson EA, Brodie MJ (2005) Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment. Epilepsia 46(5):643\u2013647","journal-title":"Epilepsia"},{"issue":"1","key":"1920_CR39","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.yebeh.2007.04.013","volume":"11","author":"P Kwan","year":"2007","unstructured":"Kwan P, Baum L, Wong V, Ng PW, Lui CH, Sin NC, Hui ACF, Yu E, Wong LKS (2007) Association between ABCB1 C3435T polymorphism and drug-resistant epilepsy in Han Chinese. Epilepsy Behav 11(1):112\u2013117. https:\/\/doi.org\/10.1016\/j.yebeh.2007.04.013 (Epub 2007 May 22)","journal-title":"Epilepsy Behav"},{"key":"1920_CR40","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.seizure.2006.02.015","volume":"15","author":"DW Kim","year":"2006","unstructured":"Kim DW, Kim M, Lee SK, Kang R, Lee S-Y (2006) Lack of association between C3435T nucleotide MDR1 genetic polymorphism and multidrug-resistant epilepsy. Seizure 15:344\u2013347","journal-title":"Seizure"},{"issue":"1\u20132","key":"1920_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000109264","volume":"59","author":"GO Ozgon","year":"2008","unstructured":"Ozgon GO, Bebek N, Gul G, Cine N (2008) Association of MDR1 (C3435T) polymorphism and resistance to carbamazepine in epileptic patients from Turkey. Eur Neurol 59(1\u20132):67\u201370","journal-title":"Eur Neurol"},{"issue":"6","key":"1920_CR42","first-page":"416","volume":"70","author":"L Zhou","year":"2015","unstructured":"Zhou L, Cao Y, Long H, Long L, Lin Xu, Liu Z, Zhang Y, Xiao Bo (2015) ABCB1, ABCC2, SCN1A, SCN2A, GABRA1 gene polymorphisms and drug resistant epilepsy in the Chinese Han population. Pharmazie 70(6):416\u2013420","journal-title":"Pharmazie"},{"issue":"9","key":"1920_CR43","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.biochi.2010.04.008","volume":"92","author":"S Grover","year":"2010","unstructured":"Grover S, Bala K, Sharma S, Gourie-Devi M, Baghel R, Kaur H, Gupta M, Talwar P, Kukreti R (2010) Absence of a general association between ABCB1 genetic variants and response to antiepileptic drugs in epilepsy patients. Biochimie 92(9):1207\u20131212","journal-title":"Biochimie"},{"key":"1920_CR44","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/j.1755-5949.2012.00336.x","volume":"18","author":"Qu Jian","year":"2012","unstructured":"Jian Qu, Zhou B-T, Yin J-Y, Xiao-Jing Xu, Zhao Y-C, Lei G-H, Tang Q, Zhou H-H, Liu Z-Q (2012) ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients. CNS Neurosci Ther 18:647\u2013651","journal-title":"CNS Neurosci Ther"},{"issue":"5","key":"1920_CR45","doi-asserted-by":"publisher","first-page":"64827","DOI":"10.1371\/journal.pone.0064827","volume":"8","author":"S Subenthiran","year":"2013","unstructured":"Subenthiran S, Abdullah NR, Joseph JP, Muniandy PK, Mok BT, Kee CC, Ismail Z, Mohamed Z (2013) Linkage disequilibrium between polymorphisms of ABCB1 and ABCC2 to predict the treatment outcome of Malaysians with complex partial seizures on treatment with carbamazepine mono-therapy at the Kuala Lumpur Hospital. PLoS\u00a0One 8(5):64827","journal-title":"PLoS\u00a0One"},{"issue":"1391","key":"1920_CR46","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.brainres.2011.03.028","volume":"19","author":"L Dong","year":"2011","unstructured":"Dong L, Rong Luo Yu, Tong XC, Mao M, Dan Yu (2011) Lack of association between ABCB1 gene polymorphisms and pharmacoresistant epilepsy: an analysis in a western Chinese pediatric population. Brain Res 19(1391):114\u2013124. https:\/\/doi.org\/10.1016\/j.brainres.2011.03.028 (Epub 2011 Mar 21)","journal-title":"Brain Res"},{"issue":"15","key":"1920_CR47","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.2217\/pgs.14.142","volume":"15","author":"X Zhu","year":"2014","unstructured":"Zhu X, Yun W, Sun X, Qiu F, Zhao L, Guo Y (2014) Effects of major transporter and metabolizing enzyme gene polymorphisms on carbamazepine metabolism in Chinese patients with epilepsy. Pharmacogenomics 15(15):1867\u20131879","journal-title":"Pharmacogenomics"},{"issue":"4","key":"1920_CR48","doi-asserted-by":"publisher","first-page":"551","DOI":"10.2217\/14622416.7.4.551","volume":"7","author":"T Seo","year":"2006","unstructured":"Seo T, Ishitsu T, Ueda N, Nakada N, Yurube K, Ueda K, Nakagawa K (2006) ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients. Pharmacogenomics 7(4):551\u2013561","journal-title":"Pharmacogenomics"},{"issue":"2","key":"1920_CR49","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.eplepsyres.2013.11.009","volume":"108","author":"DKV Uzma Shaheen","year":"2014","unstructured":"Uzma Shaheen DKV, Prasad VS, Suryaprabha T, Ahuja YR, Jyothy A, Munshi A (2014) Significance of MDR1 gene polymorphism C3435T in predicting drug response in epilepsy. Epilepsy Res 108(2):251\u2013256","journal-title":"Epilepsy Res"},{"key":"1920_CR50","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.seizure.2011.01.008","volume":"20","author":"BS Haerian","year":"2011","unstructured":"Haerian BS, Lim KS, Mohameda EHM, Tan HJ, Tan CT, Raymond AA, Wongd CP, Wongc SW, Mohameda Z (2011) Lack of association of ABCB1 and PXR polymorphisms with response to treatment in epilepsy. Seizure 20:387\u2013394","journal-title":"Seizure"},{"issue":"2","key":"1920_CR51","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2217\/pgs.11.141","volume":"13","author":"C-C Hung","year":"2012","unstructured":"Hung C-C, Chang W-L, Ho J-L, Tai JJ, Hsieh T-J, Huang H-C, Hsieh Y-W, Liou H-H (2012) Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization. Pharmacogenomics 13(2):159\u2013169","journal-title":"Pharmacogenomics"},{"key":"1920_CR52","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.eplepsyres.2015.09.001","volume":"117","author":"P Wang","year":"2015","unstructured":"Wang P, Yin T, Ma H-Y, Liu D-Q, Sheng Y-H, Wang C, Zhou B-T (2015) Effects of CYP3A4\/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and biotherapy. Epilepsy Res 117:52\u201357","journal-title":"Epilepsy Res"},{"issue":"3","key":"1920_CR53","first-page":"89","volume":"14","author":"M Maleki","year":"2010","unstructured":"Maleki M, Sayyah M, Kamgarpour F, Karimipoor M, Arab A, Rajabi A, Gharagozli K, Shamshiri AR, Ananloo ES (2010) Association between ABCB1-T1236C polymorphism and drug-resistant epilepsy in Iranian female patients. Iran Biomed J 14(3):89\u201396","journal-title":"Iran Biomed J"},{"issue":"1","key":"1920_CR54","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.yebeh.2011.02.015","volume":"21","author":"H Meng","year":"2011","unstructured":"Meng H, Guo G, Ren J, Zhou H, Ge Y, Guo Y (2011) Effects of ABCB1 polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy. Epilepsy Behav 21(1):27\u201330","journal-title":"Epilepsy Behav"},{"key":"1920_CR55","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1101\/gr.184901","volume":"11","author":"M Dean","year":"2001","unstructured":"Dean M, Rzhetsky A, Allikmets R (2001) The human ATP-binding cassette (ABC) transporter superfamily. Genome Res 11:1156\u20131166","journal-title":"Genome Res"},{"key":"1920_CR56","volume-title":"ABC proteins: from bacteria to man","author":"IB Holland","year":"2003","unstructured":"Holland IB, Cole SPC, Kuchler K, Higgins CF (2003) ABC proteins: from bacteria to man. Academic Press, Amsterdam"},{"key":"1920_CR57","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0005-2736(99)00161-3","volume":"1461","author":"I Klein","year":"1999","unstructured":"Klein I, Sarkadi B, V\u00e1radi A (1999) An inventory of the human ABC proteins. Biochim Biophys Acta 1461:237\u2013262","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"1920_CR58","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1101\/gr.184901","volume":"11","author":"M Dean","year":"2001","unstructured":"Dean M, Rzhetsky A, Allikmets R (2001) The human ATP-binding cassette (ABC) transporter superfamily. Genome Res 11(7):1156\u20131166. https:\/\/doi.org\/10.1101\/gr.184901","journal-title":"Genome Res"},{"issue":"16","key":"1920_CR59","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1093\/jnci\/92.16.1295","volume":"92","author":"P Borst","year":"2000","unstructured":"Borst P, Evers R, Kool M, Wijnholds J (2000) A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 92(16):1295\u20131302. https:\/\/doi.org\/10.1093\/jnci\/92.16.1295","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"1920_CR60","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1212\/01.wnl.0000141021.42763.f6","volume":"63","author":"F Zimprich","year":"2004","unstructured":"Zimprich F, Sunder-Plassmann R, Stogmann E et al (2004) Association of an ABCB1 gene haplotype with pharmacoresistance in temporal lobe epilepsy. Neurology 63(6):1087\u20131089. https:\/\/doi.org\/10.1212\/01.wnl.0000141021.42763.f6","journal-title":"Neurology"},{"key":"1920_CR61","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.bcp.2017.05.012","volume":"140","author":"K Muhrez","year":"2017","unstructured":"Muhrez K, Largeau B, Emond P et al (2017) Single nucleotide polymorphisms of ABCC2 modulate renal secretion of endogenous organic anions. Biochem Pharmacol 140:124\u2013138. https:\/\/doi.org\/10.1016\/j.bcp.2017.05.012","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"1920_CR62","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12987-017-0054-5","volume":"14","author":"K Ibbotson","year":"2017","unstructured":"Ibbotson K, Yell J, Ronaldson PT (2017) Nrf2 signaling increases expression of ATP-binding cassette subfamily C mRNA transcripts at the blood-brain barrier following hypoxia-reoxygenation stress. Fluids Barriers CNS 14(1):6. https:\/\/doi.org\/10.1186\/s12987-017-0054-5","journal-title":"Fluids Barriers CNS"},{"issue":"2","key":"1920_CR63","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0304-4157(95)00006-D","volume":"1241","author":"RP Oude Elferink","year":"1995","unstructured":"Oude Elferink RP, Kuipers F, Jansen PL, Groen AK, Groothuis GM (1995) Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport. Biochim Biophys Acta 1241(2):215\u2013268","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl 1","key":"1920_CR64","first-page":"100","volume":"24","author":"M Muller","year":"1996","unstructured":"Muller M, de Vries EG et al (1996) Role of multidrug resistance protein (MRP) in glutathione S-conjugate transport in mammalian cells. J Hepatol 24(Suppl 1):100\u2013108","journal-title":"J Hepatol"},{"issue":"4","key":"1920_CR65","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/FPC.0b013e328338073a","volume":"20","author":"W-J Kim","year":"2010","unstructured":"Kim W-J, Lee JH, Yi J, Cho Y-J, Heo K, Lee SH, Kim SW, Kim M-K, Kim KH, Lee BI, Lee MG (2010) A nonsynonymous variation in MRP2\/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy. Pharmacogenet Genomics 20(4):249\u2013256","journal-title":"Pharmacogenet Genomics"},{"issue":"1","key":"1920_CR66","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2217\/pgs.12.180","volume":"14","author":"YG Puranik","year":"2013","unstructured":"Puranik YG, Birnbaum AK, Marino SE, Ahmed G, Cloyd JC, Remmel RP, Leppik IE, Lamba JK (2013) Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy. Pharmacogenomics 14(1):35\u201345. https:\/\/doi.org\/10.2217\/pgs.12.180","journal-title":"Pharmacogenomics"},{"issue":"5","key":"1920_CR67","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3389\/fneur.2014.00184","volume":"9","author":"D Escalante-Santiago","year":"2014","unstructured":"Escalante-Santiago D, Feria-Romero IA, Ribas-Aparicio RM, Rayo-Mares D, Fagiolino P, V\u00e1zquez M, Escamilla-N\u00fa\u00f1ez C, Grijalva-Otero I, L\u00f3pez-Garc\u00eda MA, Orozco-Su\u00e1rez S (2014) MDR-1 and MRP2 gene polymorphisms in Mexican epileptic pediatric patients with complex partial seizures. Front Neurol 9(5):184. https:\/\/doi.org\/10.3389\/fneur.2014.00184","journal-title":"Front Neurol"},{"key":"1920_CR68","first-page":"2349","volume":"11","author":"SH Park","year":"1995","unstructured":"Park SH, Weinberg RA (1995) A putative effector of Ral has homology to Rho\/Rac GTPase activating proteins. Oncogene 11:2349\u20132355","journal-title":"Oncogene"},{"issue":"16","key":"1920_CR69","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1242\/jcs.113.16.2837","volume":"113","author":"V Jullien-Flores","year":"2000","unstructured":"Jullien-Flores V, Mahe Y, Mirey G, Leprince C, Meunier-Bisceuil B, Sorkin A, Camonis JH (2000) RLIP76, an effector of the GTPase Ral, interacts with the AP2 complex: involvement of the Ral pathway in receptor endocytosis. J Cell Sci 113(16):2837\u20132844","journal-title":"J Cell Sci"},{"key":"1920_CR70","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1128\/MCB.15.8.4578","volume":"15","author":"SB Cantor","year":"1995","unstructured":"Cantor SB, Urano T, Feig LA (1995) Identification and characterization of Ral-binding protein 1, a potential downstream target of Ral GTPases. Mol Cell Biol 15:4578\u20134584","journal-title":"Mol Cell Biol"},{"issue":"Pt 5","key":"1920_CR71","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1242\/jcs.112.5.707","volume":"112","author":"A Quaroni","year":"1999","unstructured":"Quaroni A, Paul EC (1999) Cytocentrin is a Ral-binding protein involved in the assembly and function of the mitotic apparatus. J Cell Sci 112(Pt 5):707\u2013718","journal-title":"J Cell Sci"},{"key":"1920_CR72","doi-asserted-by":"publisher","first-page":"693","DOI":"10.18388\/abp.2002_3778","volume":"49","author":"R Sharma","year":"2002","unstructured":"Sharma R, Sharma A, Yang Y, Awasthi S, Singhal SS, Zimniak P, Awasthi YC (2002) Functional reconstitution of Ral-binding GTPase activating protein, RLIP76, in proteoliposomes catalyzing ATP-dependent transport of glutathione conjugate of 4- hydroxynonenal. Acta Biochim Pol 49:693\u2013701","journal-title":"Acta Biochim Pol"},{"issue":"6","key":"1920_CR73","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1471-2202-6-61","volume":"27","author":"S Awasthi","year":"2005","unstructured":"Awasthi S, Hallene KL, Fazio V, Singhal SS, Cucullo L, Awasthi YC, Dini G, Janigro D (2005) RLIP76, a non-ABC transporter, and drug resistance in epilepsy. BMC Neurosci 27(6):61\u201372","journal-title":"BMC Neurosci"},{"issue":"4","key":"1920_CR74","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1528-1167.2007.00926.x","volume":"48","author":"N Soranzo","year":"2007","unstructured":"Soranzo N, Kelly L, Martinian L, Burley MW, Thom M, Sali A, Kroetz DL, Goldstein DB, Sisodiya SM (2007) Lack of support for a role for RLIP76 (RALBP1) in response to treatment or predisposition to epilepsy. Epilepsia 48(4):674\u2013683","journal-title":"Epilepsia"},{"key":"1920_CR75","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/j.1528-1167.2006.00496.x","volume":"47","author":"EA Van Vliet","year":"2006","unstructured":"Van Vliet EA, van Schaik R, Edelbroek PM, Redeker S, Aronica E, Wadman WJ et al (2006) Inhibition of the multidrug transporter P-glycoproteinimproves seizure control in phenytoin-treated chronic epileptic rats. Epilepsja 47:672\u2013680","journal-title":"Epilepsja"},{"key":"1920_CR76","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.2217\/14622416.8.12.1715","volume":"8","author":"GD Leschziner","year":"2007","unstructured":"Leschziner GD, Jorgensen AL, Andrew T, Williamson PR, Marson AG, Coffey AJ et al (2007) The association between polymorphisms in RLIP76 and drug response in epilepsy. Pharmacogenomics 8:1715\u20131722","journal-title":"Pharmacogenomics"},{"issue":"1","key":"1920_CR77","first-page":"230","volume":"14","author":"E Manguo\u011flu","year":"2011","unstructured":"Manguo\u011flu E, Akdeniz S, D\u00fcndar NO, Duman \u00d6, Aktekin B, Haspolat \u015e, Bilge U, \u00d6zel D, L\u00fcleci G (2011) RLIP76 gene variants are not associated with drug response in turkish epilepsy patients. BJMG 14(1):230","journal-title":"BJMG"},{"issue":"1","key":"1920_CR78","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.yebeh.2008.08.019","volume":"14","author":"R Lakhan","year":"2009","unstructured":"Lakhan R, Misra UK, Kalita J, Pradhan S, Gogtay NJ, Singh MK, Mittal B (2009) No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population. Epilepsy Behav 14(1):78\u201382","journal-title":"Epilepsy Behav"},{"issue":"4","key":"1920_CR79","doi-asserted-by":"publisher","first-page":"5937","DOI":"10.4238\/2013.November.26.3","volume":"12","author":"S Subenthiran","year":"2013","unstructured":"Subenthiran S, Abdullah NR, Muniandy PK, Joseph JP, Cheong KC, Ismail Z, Mohamed Z (2013) G2677T polymorphism can predict treatment outcome of Malaysians with complex partial seizures being treated with Carbamazepine. Genet Mol Res 12(4):5937\u20135944","journal-title":"Genet Mol Res"},{"issue":"17","key":"1920_CR80","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.2217\/pgs-2016-0078","volume":"17","author":"I Fricke-Galindo","year":"2016","unstructured":"Fricke-Galindo I, Ortega-V\u00e1zquez A, Monroy-Jaramillo N, Dorado P, Jung-Cook H, Pe\u00f1as-Lled\u00f3 E, LLerena A, L\u00f3pez-L\u00f3pez M (2016) Allele and genotype frequencies of genes relevant to anti-epileptic drug therapy in Mexican-Mestizo healthy volunteers. Pharmacogenomics 17(17):1913\u20131930","journal-title":"Pharmacogenomics"},{"key":"1920_CR81","doi-asserted-by":"publisher","first-page":"1343650","DOI":"10.1155\/2019\/1343650","volume":"2019","author":"M Chouchi","year":"2019","unstructured":"Chouchi M, Klaa H, Turki IB-Y, Hila L (2019) ABCB1 polymorphisms and drug-resistant epilepsy in a Tunisian population. Dis Markers 2019:1343650. https:\/\/doi.org\/10.1155\/2019\/1343650","journal-title":"Dis Markers"},{"key":"1920_CR82","doi-asserted-by":"publisher","first-page":"22473","DOI":"10.1074\/jbc.270.38.22473","volume":"270","author":"V Jullien-Flores","year":"1995","unstructured":"Jullien-Flores V, Dorseuil O, Romero F, Letourneur F, Saragosti S, Berger R, Tavitian A, Gacon G, Camonis JH (1995) Bridging Ral GTPase to Rho pathways RLIP76, a Ral effector with CDC42\/Rac GTPase-activating protein activity. J Biol Chem 270:22473\u201322477","journal-title":"J Biol Chem"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-022-01920-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-022-01920-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-022-01920-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T18:15:59Z","timestamp":1658340959000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-022-01920-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1920"],"URL":"https:\/\/doi.org\/10.1007\/s13760-022-01920-5","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,24]]},"assertion":[{"value":"26 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare: there is no conflict of interest, and non-financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}